Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 7 Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Malignant Solid Neoplasm 2 Head and Neck Carcinoma 2 Fallopian Tube Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Ureteral Neoplasms 1 Tonsillar Neoplasms 1 Tongue Neoplasms 1 Teratoma 1 Stomatitis 1 Spondylitis, Ankylosing 1 Psoriasis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1

Interventions

Cyclophosphamide 28 fludarabine 19 Rituximab 17 obinutuzumab 12 venetoclax 10 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 ibrutinib 5 fludarabine phosphate 5 Biopsy 5 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Practice Guidelines as Topic × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡